Evidence map›Paper›PMID 31520838›Full record

ArticleThe journal of allergy and clinical immunology. In practice2020

Do Baseline Asthma and Allergic Sensitization Characteristics Predict Responsiveness to Mouse Allergen Reduction?

Ammara Ahmed, S Christy Sadreameli, Jean Curtin-Brosnan, Torie Grant, Wanda Phipatanakul, Matthew Perzanowski, Susan Balcer-Whaley, Roger Peng, Michelle Newman, Amparito Cunningham and 6 more

Open access · greenAbstract read
In one paragraph

Article in The journal of allergy and clinical immunology. In practice, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 1 country.

Ammara AhmedDivision of Pediatric Allergy/Immunology, Johns Hopkins University School of Medicine, Baltimore, Md.
S Christy SadreameliDivision of Pediatric Pulmonology, Johns Hopkins University School of Medicine, Baltimore, Md.
Jean Curtin-BrosnanDivision of Pediatric Allergy/Immunology, Johns Hopkins University School of Medicine, Baltimore, Md.
Torie GrantDivision of Pediatric Allergy/Immunology, Johns Hopkins University School of Medicine, Baltimore, Md.
Wanda PhipatanakulDivision of Pediatric Allergy/Immunology, Boston Children's Hospital, Harvard University Medical School, Boston, Mass.
Matthew PerzanowskiDepartment of Environmental Health Sciences, Mailman School of Public Health, Columbia University, New York, NY.
Susan Balcer-WhaleyDivision of Pediatric Allergy/Immunology, Johns Hopkins University School of Medicine, Baltimore, Md.
Roger PengDepartment of Biostatistics, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Md.
Michelle NewmanDivision of Pediatric Allergy/Immunology, Johns Hopkins University School of Medicine, Baltimore, Md.
Amparito CunninghamDivision of Pediatric Allergy/Immunology, Boston Children's Hospital, Harvard University Medical School, Boston, Mass.
Adnan DivjanDepartment of Environmental Health Sciences, Mailman School of Public Health, Columbia University, New York, NY.
Mary E BollingerDepartment of Pediatrics, University of Maryland School of Medicine, Baltimore, Md.
Robert A WiseDivision of Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, Md.
Rachel MillerDivision of Pulmonary, Allergy and Critical Care Medicine, College of Physicians and Surgeons, Columbia University, New York, NY.
Ginger ChewDepartment of Environmental Health Sciences, Mailman School of Public Health, Columbia University, New York, NY.
Elizabeth C MatsuiDepartment of Population Health and Pediatrics, Dell Medical School at the University of Texas, Austin, Tex. Electronic address: Elizabeth.matsui@austin.utexas.edu.
Johns Hopkins University · USColumbia University · USHarvard University · USJohns Hopkins Medicine · USThe University of Texas at Austin · USUniversity of Maryland, Baltimore · US

Funding

True Metal fac coreP30ES009089 · NIEHS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MATTHEW S PERZANOWSKI · 1998 to 2026
$44.7M
ZINC AND CA EDTA THERAPY OF PLUMBISMM01RR000052 · NCRR · JOHNS HOPKINS UNIVERSITY · PI MARSH, LAURA · 1985 to 2007
$37.3M
Oxidative Stress & Inflammation in a Human PM Nasal ChallengeP50ES015903 · NIEHS · JOHNS HOPKINS UNIVERSITY · PI MATSUI, ELIZABETH C. · 2007 to 2011
$12.1M
Mouse Allergen and Asthma Intervention TrialU01AI083238 · NIAID · JOHNS HOPKINS UNIVERSITY · PI MATSUI, ELIZABETH C. · 2010 to 2014
$7.9M
The effect of a housing mobility program on environmental exposures and asthma morbidity among low-income minority childrenR01ES026170 · NIEHS · JOHNS HOPKINS UNIVERSITY · PI KEET, CORINNE, MATSUI, ELIZABETH C. · 2016 to 2025
$6.8M
RESEARCH TRAINING IN PEDIATRIC ALLERGY &IMMUNOLOGYT32AI007007 · NIAID · JOHNS HOPKINS UNIVERSITY · PI ROBERT A WOOD · 1985 to 2026
$5.4M
Scientific & Technical CoreP2CHD042849 · NICHD · UNIVERSITY OF TEXAS AT AUSTIN · PI MARK D. HAYWARD · 2017 to 2026
$5.2M
Project 3: Dissecting the Diet Asthma Relationship in Mice Models of AsthmaP01ES018176 · NIEHS · JOHNS HOPKINS UNIVERSITY · PI DIETTE, GREGORY B · 2009 to 2013
$4.2M
Environmental Control as Add-on Therapy in Urban Children with AsthmaR01ES023447 · NIEHS · JOHNS HOPKINS UNIVERSITY · PI MATSUI, ELIZABETH C. · 2014 to 2018
$3.4M
Mouse Allergen and Inner-City AsthmaR01AI070630 · NIAID · JOHNS HOPKINS UNIVERSITY · PI MATSUI, ELIZABETH C. · 2006 to 2010
$1.9M
Midcareer Investigator Award: Urban School Allergen Exposures and Childhood AsthmK24AI106822 · NIAID · BOSTON CHILDREN'S HOSPITAL · PI PHIPATANAKUL, WANDA · 2013 to 2022
$1.9M
Mentoring in Patient-Oriented Research on Asthma and the Indoor EnvironmentK24AI114769 · NIAID · UNIVERSITY OF TEXAS AT AUSTIN · PI MATSUI, ELIZABETH C. · 2015 to 2023
$1.6M
NCRR NIH HHS M01 RR000052NIAID NIH HHS K24 AI106822NIAID NIH HHS K24 AI114769NIAID NIH HHS R01 AI070630NIAID NIH HHS R34 AI074928NIAID NIH HHS T32 AI007007NIAID NIH HHS U01 AI083238NICHD NIH HHS P2C HD042849NIEHS NIH HHS P01 ES018176NIEHS NIH HHS P30 ES009089NIEHS NIH HHS P50 ES015903NIEHS NIH HHS R01 ES023447NIEHS NIH HHS R01 ES026170
6 · The paper itself

Abstract

backgroundMouse allergen reduction is associated with improvements in asthma among sensitized and exposed children, but whether clinical characteristics predict responsiveness to allergen reduction is unclear.

objectiveTo examine the effects of clinical characteristics on relationships between mouse allergen reduction and asthma outcomes.

methodsWe performed a secondary analysis of data from a randomized clinical trial of a mouse allergen intervention, examining the effects of atopy, demographic characteristics, lung function, asthma control, and asthma severity on relationships between mouse allergen reduction and asthma outcomes.

resultsParticipants were predominantly low-income and minority (78% black, 22% Hispanic), and had persistent asthma. Among less atopic participants (<6 positive skin prick test results), each 50% reduction in mouse allergen was associated with fewer symptoms (incidence rate ratio [95% CI]: maximal symptoms: 0.94 [0.92-0.96]). There was little effect of mouse allergen reduction on symptoms among more atopic participants (P > .05). The interactions between atopic status and mouse allergen reduction were statistically significant for all symptom outcomes; however, there was no evidence that atopic status influenced the effect of mouse allergen reduction on exacerbation-related outcomes. Older children (≥9 years) tended to experience greater improvement in some asthma outcomes with reduction in mouse allergen exposure than younger children. There was no evidence that either mouse-specific IgE or lung function influenced the effect of mouse allergen reduction on any asthma outcomes.

conclusionsAlthough there may be variability in the clinical response to mouse allergen reduction among low-income, minority children with asthma, there were no clinical characteristics that clearly identified a subgroup at which the intervention should be targeted.

Indexed as

AllergensAsthmaHypersensitivity, ImmediateAdolescentAnimalsChildHumansMaleMiceMinority GroupsPovertyRandomized Controlled Trials as TopicSkin TestsAllergensAllergen exposureAllergen exposure reductionAllergen sensitizationAllergic asthmaAtopyMouse allergen exposure

Identifiers

PMID31520838
PMCPMC7043786
OpenAlexW2972744818

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.